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Abstract:  Biochemical  detection  (BCD)  methods  are  commonly  used  to  screen  plant 
extracts for specific biological activities in batch assays. Traditionally, bioactives in the 
most active extracts were identified through time-consuming bio-assay guided fractionation 
until single active compounds could be isolated. Not only are isolation procedures often 
tedious, but they could also lead to artifact formation. On-line coupling of BCD assays to 
high performance liquid chromatography (HPLC) is gaining ground as a high resolution 
screening technique to overcome problems associated with pre-isolation by measuring the 
effects of compounds post-column directly after separation. To date, several on-line HPLC-
BCD assays, applied to whole plant extracts and mixtures, have been published. In this 
review the focus will fall on enzyme-based, receptor-based and antioxidant assays. 
Keywords:  antioxidant;  bioactive  phytochemicals;  biochemical  detection;  enzyme 
inhibition; HPLC; receptor affinity 
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1. Introduction  
Historically, plants have provided the basic building blocks for a number of highly effective drugs 
and they remain an attractive option for discovery of new molecular entities, due to their still largely 
untapped chemical diversity [1]. About 40% of the chemical scaffolds found in natural products are 
still absent in today’s medicinal chemistry [2]. The classical approach leading up to a hit or lead 
compound involves extract preparation and pre-fractionation, biological screening in pharmacologically 
relevant assays, and isolation and characterization of the active compound(s) through bioassay-guided 
fractionation [3]. Dereplication techniques allow identification of known compounds responsible for 
activity of an extract before implementation of bioassay-guided fractionation. Separation of an extract 
by  high-performance  liquid  chromatography  with  diode  array  and  mass  spectrometric  detection 
(HPLC-DAD-MS) followed by post-column splitting of the HPLC effluent to a fraction collector, 
allows collection of UV-Vis and MS spectra, as well as fractions that could be screened in an array of 
in vitro assays [1,2]. Recent progress in on-line biochemical detection (BCD), largely as a result of 
work by groups in the Netherlands (as reviewed in this paper), has seen the development of a number 
of assays that are used in tandem with HPLC-DAD and/or -MS, classified as high resolution screening 
methods. BCD assays can be defined as the detection of bioactives based on biochemical reactions or 
simulated biochemical reactions. These methods are used to fast-track identification of bioactives in 
extracts or mixtures without the need for lengthy separation and isolation procedures (see Figure 1 for 
an example). The power of this type of screening procedure is that it cuts down on in vitro testing, since 
only new target compounds, showing activity against the specific disease marker, need to be isolated 
and tested further. In this review the focus will fall on affinity/activity-based BCD methods, including 
enzyme  activity/affinity  detection  (EAD),  receptor  affinity  detection  (RAD),  metabolite  profiling 
systems, and antioxidant activity assays, as tools to identify bioactives in plant extracts amongst others. 
Figure 1. HPLC-diode array detection (DAD) (positive peaks) and on-line 2,2'-azinobis-
(3-ethylbenzothiazoline-6-sulfonate) radical cation (ABTS
•+) scavenging (negative peaks) 
profiles of an Athrixia phylicoides extract (adapted from De Beer et al. [4]; * indicates 
peaks with activity higher than that of caffeic acid). 
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2. HPLC-BCD Configurations and General Requirements 
HPLC-BCD  instrument  configurations  vary  due  to  optimization  for  specific  purposes  or  the 
preference of the research group involved, but there are several basic configurations that suit particular 
assay types (Figure 2a–d). The configurations depicted are generalized to fit most assays and variations 
from these will be discussed in the text. Most of the assays discussed in this review are set up in a  
post-chromatographic  configuration  except  the  assays  aimed  at  identifying  bioactive  metabolites, 
which also include pre-chromatographic metabolism of the sample. The simplest configuration, used 
for most on-line antioxidant assays, has no split in the HPLC effluent and only a single reaction coil 
(Figure 2a) [5]. Most EAD and RAD assays, as well as some on-line antioxidant assays, make use of 
flow-splitters to divide the HPLC effluent [6–9]. Part of the flow is directed to the BCD assay, while 
the rest can be linked to additional detectors used for compound identification or sent to waste. These 
types of assays can also include pre-incubation of the HPLC effluent with the receptors or enzymes in 
an incubated coil before the addition of the substrate, followed by a second reaction coil [10]. EAD 
and RAD assays can further be classified as homogeneous assays (Figure 2b) [11], where there is a 
marked difference in the signal intensity obtained from bound and unbound ligands, or heterogeneous 
assays (Figure 2c) [12], where a further separation step is required to distinguish between bound and 
unbound ligands. The metabolite profiling assays use a configuration where a metabolism system is 
inserted between the automatic sample injector and the HPLC gradient pump (Figure 2d) [13]. This 
system, which can be further combined with BCD systems, consists of pumps for addition of the 
reagents and a reaction coil. After reaction of the sample with the enzyme source and cofactors, the 
reaction mixture is filtered using a cross-flow filtration device. The reaction mixture is then trapped on 
a solid-phase extraction (SPE) column prior to HPLC separation. Several valves are also required to 
allow washing of the filtration device, as well as trapping of the reaction mixture on the SPE column 
and subsequent elution onto the HPLC column. 
Figure  2.  Basic  configurations  of  typical  HPLC-BCD  systems:  (a)  on-line  antioxidant 
assays; enzyme activity/affinity detection  (EAD) and receptor affinity detection  (RAD) 
assays  in  (b)  homogeneous  configuration  and  (c)  heterogeneous  configuration;  and  
(d) metabolite detection assays [ASI = automatic sample injector; B = buffer; C = cofactor; 
Det = detector; E = enzyme source/receptor; n = number; R = reagent; RAC = restricted 
access column; S = substrate; SPE = solid phase extraction; V = valve]. 
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Despite  the  different  instrument  configurations  there  are  still  some  general  considerations  and 
requirements for the successful development of any of the abovementioned HPLC-BCD assays. Firstly, 
the  chromatographic  solvents  are  rarely  compatible  with  biological  material,  such  as  enzymes, 
receptors  and  microsomal  preparations,  and  they  can  interfere  in  antioxidant  reactions.  Therefore, 
make-up flow systems are often employed to either keep the organic modifier content constant through 
addition of counter-gradients [14] or below noticeable inhibitory concentrations through the addition 
of buffer as diluent [4]. Secondly, non-specific binding of the biological material to the reaction coil 
has to be eliminated to increase the resolution in the secondary detector by increasing the signal-to-noise Int. J. Mol. Sci. 2012, 13                       
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ratio [15]. To this end, an array of additives is available with prior optimization needed to select the most 
effective additive at the optimal concentration, i.e., detergents, poly-ethylene glycol (PEG) polymers, 
ELISA blocking agent and bovine serum albumin (BSA) [15]. Use of a coil material that is resistant to 
binding  by  enzymes  and  receptors  can  also  greatly  diminish  non-specific  binding  [6,7].  Thirdly, 
several parameters need to be optimized for sensitivity. These could include reaction times, reaction 
temperature and suitable buffer systems, depending on the specific reaction. Reaction times may be 
adjusted via HPLC effluent and reagent flow rate, HPLC effluent split ratio and reaction coil volumes. 
Furthermore, biological material should be delivered to the HPLC effluent stream in a non-abrasive 
manner  which  is  best  achieved  using  syringe  pumps  or  Superloops
  (Pharmacia)  [16].  Peristaltic 
pumps, despite being prone to fluctuations in pressure, have also been used. 
Several  detectors  can  be  employed  for  detection  of  compounds  in  the  HPLC  effluent,  the 
observation  of  active  peaks  and  the  tentative  identification  of  bioactives.  In  general,  any  of  the 
substrates, ligands or receptors could be labeled with a chromophore, fluorophore or any other signal 
delivering  probe  to  enable  their  detection.  In  the  case  of  labeled  receptors,  an  affinity  column  is 
employed to retain all unbound receptors, hence, if ligands are present, i.e., potential bioactives, this 
will cause peaks observed on the secondary detector [12]. Many of the basic assay optimization steps 
are often performed in batch assays, using benchtop detectors for quantification purposes, or flow 
injection analysis (FIA) mode, i.e., excluding the chromatography step and direct injection of the test 
solution into the BCD system. In the following sections specific examples illustrating different system 
requirements will be discussed. 
3. HPLC Coupled On-Line to EAD and RAD Assays and Their Application in Metabolic Profiling 
Hyphenated BCD techniques coupled to HPLC have been developed since the early 1990’s and 
were broadly divided between EAD and RAD assays. Several reviews have been written over the past 
decades  covering  these  techniques  in  general  [17–21],  or  focusing  on  theoretical  foundations  of 
hyphenated assays [22–26] and the implementation of mass spectrometry to strengthen the sensitivity 
of the assays  [27,28]. However, the  rather broad description of EAD  or RAD does not  take  into 
account that some hyphenated techniques are based on the metabolism of compounds and not their 
affinity for the enzymes responsible for the metabolism. These include systems using cytochromes 
P450 and liver slices [13,29–31]. Furthermore, there are also assays where HPLC is combined with 
bio-affinity compounds which may be based on orphan receptors and others based on immunological 
assays with both types not employing ―classical‖ receptors [32–37]. BCD assays based on enzymes 
and receptors could thus be divided broadly into four categories: (1) enzyme affinity/activity detection; 
(2) receptor affinity detection; (3) application of EAD and RAD in metabolite profiling and (4) assays 
employing antibody interactions. This review will concentrate on the first three categories. The major 
criteria when evaluating the various assays summarized in this review were sensitivity of the assays to 
show affinity of compounds for receptors or enzymes and the specificity with which such binding 
occur. Table 1 summarizes the EAD and RAD assays discussed in this review. Int. J. Mol. Sci. 2012, 13                       
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Table 1. Summary of HPLC-EAD and -RAD assays with emphasis on detection methods 
and relevant therapeutic areas of bioactives. 
Assay  Detection  Relevance 
EAD assays     
Acetylcholinesterase inhibitors 
[6,7,38–41] 
UV-Vis, 405 nm [6,7,38] 
FL, λex 406nm, λem 505 nm [39,40] 
ESI-MS [41] 
Treatment of Alzheimer’s disease, 
senile dementia, Parkinson’s disease, 
ataxia and myasthenia gravis 
α-Glucosidase inhibitors [14,42]  UV-Vis, 405 nm [14,42]  Treatment of diabetes type II 
Angiotensin 1 converting  
enzyme [10] 
FL, λex 320 nm, λem 420 nm [10] 
Treatment of hypertension, cardiac 
disease, diabetic nephropathy 
Liver cytochrome P450 ligands 
[15,43–45] 
FL, λex 530 nm, λem 586 nm [15,43] 
FL, λex 530 nm, λem 590 nm [44] 
FL, λex 530 nm, λem 580 nm [45] 
Cancer prevention 
Glutathione-S-transferase  
inhibitors [16,46] 
FL, λex 290 nm, λem 465 nm [16,46]  Enhancement of anticancer treatments 
Serine protease inhibitors [47]  FL, λex 342 nm, λem 440 nm [47]  Treatment of thrombosis 
HIV-protease inhibitor [48,49]  FL, λex 340 nm, λem 490 nm [48,49]  Treatment of AIDS 
Phosphodiesterase inhibitors [50]  FL, λex 280 nm, λem 460 nm [50] 
Treatment of hypertension, vascular 
conditions and asthma 
Kinase/phosphatase inhibitors [51]  FL, λex 425 nm, λem 464 nm [51]  Novel drug targets 
MAP-kinase inhibitors [52] 
FL, λex 355 ±  4 nm,  
λem 405 ±  5 nm [52] 
Treatment of inflammatory diseases 
RAD assays     
Estrogen receptor ligands 
[8,11,13,30,53–55] 
FL, λex 340 nm, λem 410 nm 
[8,11,13,30,53,54] 
FP, λex 485 nm, λem 520 nm [55] 
Hormone replacement therapy, 
chemoprevention, detecting endocrine 
disruptors 
Urokinase plasminogen activator 
receptor ligands [12] 
FL, λex 489 nm, λem 520 nm [12] 
Important role in angiogenesis, 
inflammation, wound repair and tumor 
metastasis 
AIDS,  acquired  immune  deficiency  syndrome;  ESI-MS,  electrospray  ionization  mass  spectrometry;  
FL, fluorescence; FP, fluorescence polarization; HIV, human immunodeficiency virus; UV-Vis, ultraviolet 
and visual spectrum. 
3.1. EAD Assays 
EAD assays are mainly used in the search for inhibitors of certain enzymes implicated in disease 
states. There are also some applications where enzyme activities were used to identify proteases and 
microperoxidases in complex mixtures based on substrate fluorescence. In the current section, assays 
are grouped in terms of the enzymes under investigation to emphasize the developments that took 
place within each assay type. 
Acetylcholinesterases  (AChE)  are  implicated  in  diseases  such  as  Alzheimer’s  disease,  senile 
dementia, Parkinson’s disease, ataxia and myasthenia gravis [56]. By hydrolyzing acetylcholine into 
acetate and choline, this enzyme removes the highly active neurotransmitter from the synaptic cleft to 
prevent  overstimulation.  However,  in  the  mentioned  disease  states  a  diminished  secretion  of 
acetylcholine has been implicated as a possible causal factor, thereby focusing research on AChE 
inhibitors as possible therapeutics. Int. J. Mol. Sci. 2012, 13                       
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Ingkaninan et al. [6,7] developed a BCD assay based on AChE to search for plant derived AChE 
inhibitors. Their search was initiated by the hepatotoxic nature of tacrine (tetrahydroaminoacridine), an 
FDA-approved AChE inhibitor, the discovery of galanthamine from Narcissus spp. and its subsequent 
approval as therapeutic in Austria. Their assay used 5,5'-dithiobis-[2-nitro-benzoic acid] as indicator to 
react with thiocholine that forms when acetylthiocholine is hydrolyzed by AChE. This reaction causes 
an increase in absorbance at 405 nm which could be measured by UV-Vis detection. Under assay 
conditions, buffered in Tris-HCl buffer (50 mM, pH 8) at room temperature, a stable color reaction 
was achieved with AChE from electric eel (Type VI-S) and inhibitors were observed as negative peaks. 
All  four reagents  were  added using HPLC pumps in  a configuration  analogous  to  Figure  2b, but 
without the first coil. Neither Tween 80 (polyoxyethylenesorbitan monooleate) nor BSA neutralized 
non-specific binding, but the use of polyether ether ketone (PEEK), polytetrafluoroethylene (PTFE) 
and  perfluoroalkoxy  (PFA)  instead  of  plastic,  fluorinated  ethylene  propylene  and  Tefzel  as  coil 
material showed a marked decrease in background for these assays. All optimization experiments were 
performed in FIA mode with a knitted PFA coil. Organic modifiers proved to have a marked effect on 
enzyme activity with 10% acetonitrile or 0.25% acetic acid inhibiting AChE by 90%. The inhibitory 
effect  of  10%  methanol,  on  the  other  hand,  was  less  than  50%.  Even  though  methanol  had  an 
inhibitory effect on AChE, it also decreased non-specific binding in the coil, thereby improving the 
assay resolution. During this optimization process the known AChE inhibitors, physostigmine and 
galanthamine, were used and varying concentrations injected to determine the detection limits of the 
assay. The results were also compared to that obtained with batch assays. When centrifugal partition 
chromatography  (CPC)  fractions  of  methanolic  Narcissus  bulb  extracts  were  analyzed  using  the 
HPLC-BCD  assay,  an  extra  inhibitory  peak  was  observed  [6].  In  follow-up  work  after  further 
purification of ethanolic bulb extracts by CPC and structure elucidation using electrospray ionization 
(ESI)-MS and 
1H NMR experiments, the peak was identified as ungiminorine, a mild AChE inhibitor [7]. 
It  was  suggested  that  improvements  in  the  sensitivity  might  be  achieved  by  BCD  based  on 
fluorescence, as well as decreasing band broadening and noise. Fabel et al. [38] developed an intricate 
system, named Segmented Flow Enzyme Inhibition Detection, to decrease band broadening in the 
secondary detector and improve resolution by segmenting the BCD effluent. To illustrate this system 
they employed the same colorimetric method devised by Ingkaninan et al. [6], but with additional 
components to enable segmentation of the flow by the addition of air into the BCD effluent. 
Rhee et al. [39] developed a fluorometric method for the detection of AChE inhibitors in FIA mode. 
By  employing  a  fluorogenic  substrate,  7-acetoxy-1-methyl  quinolium  iodide  (AMQI),  which  is 
hydrolyzed  to  the  fluorescent  7-hydroxy-1-methyl  quinolium  iodide  by  AChE,  they  improved  the 
sensitivity of the BCD assay 20-fold. Optimization was performed in FIA mode and showed 70% 
enzyme activity in the presence of 30% methanol or 5% acetonitrile. Furthermore, a sodium phosphate 
buffer at pH 7 was used in the assay with the exception of the substrate, which was stored at 0 °C  in 
the same buffer at pH 5 for enhanced stability. The substrate and enzyme were added to the system using 
peristaltic pumps. BSA was used to eliminate non-specific binding, thereby improving assay resolution. 
Twenty  nine  plant  extracts  of  various  origins  were  screened  with  extracts  from  bulbs  of  species  
from the Amaryllidaceae family showing high inhibitory activity towards AChE. These results were 
compared with those of batch assays using the colorimetric assay as described by Ingkaninan et al. [6]. 
Marques et al. [40] recently used a modification of this fluorogenic method coupled to HPLC to study Int. J. Mol. Sci. 2012, 13                       
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the AChE inhibitory activity of tacrine metabolites. Their modifications included continuous addition 
of AChE and AMQI to the HPLC effluent using Superloops
 kept on ice. Inhibitory compounds were 
detected as negative peaks on the chromatogram obtained with fluorescence detection. UV and high 
resolution quadropole time-of-flight (Q-TOF) MS/MS analyses of the HPLC effluent were used for 
quantification and identification of compounds, respectively. The study indicated that the synthesis of 
chemical or biological degradation products of drugs could lead to the improvement of therapeutic 
treatments. For a more direct method of analysis ESI-MS could be employed to measure the hydrolysis 
of  acetylcholine  to  acetate  and  choline  by  AChE  [41].  By  continuously  monitoring  the  levels  of 
choline in the BCD effluent by MS a decrease in the activity of the enzyme can be observed, which is 
then directly correlated to active compounds. This approach was similar to studies where inhibition of 
cathepsin B, linked to HPLC and high temperature liquid chromatography, was used to illustrate the 
advantages of MS in BCD [57,58]. Recently, Kool et al. [59] devised an assay in the off-line mode for 
detecting acetylcholine binding protein of fractions spotted into 1536-well plates. 
α-Glucosidases are prime targets for anti-diabetic therapeutics in the search for compounds to curb 
the rise in diabetes mellitus type II [60]. By inhibiting the hydrolysis of polysaccharides to glucose in 
the intestine, glucose absorption can be limited, thereby lowering the blood glucose content. In recent 
years  a  simple  spectrophotometric  assay  based  on  the  reaction  of  α-glucosidase  from  the  yeast 
Saccharomyces cerevisiae with the chromogenic substrate, p-nitrophenyl-α-glucopyranoside (pNPG), 
has been applied in the search for α-glucosidase inhibitors in plant extracts [61]. In this assay the  
p-nitrophenyl  group  is  spliced  from  pNPG  with  a  subsequent  increase  in  absorbance  at  405  nm.  
If an extract contains inhibitors, it will cause a decreased absorbance at 405 nm relative to the control 
containing no inhibitors. 
Li et al. [14] developed an HPLC-BCD method based on this colorimetric assay using α-glucosidase 
from yeast and an instrument configuration similar to that depicted in Figure 2b, but simplified by 
excluding the first coil. Using reversed phase HPLC and DAD for both the HPLC effluent and the 
BCD, methanolic extracts of pu-erh tea, eagle tea and radix glycyrrhizae were tested for the presence 
of α-glucosidase inhibitors. ESI-MS detection was used for the tentative identification of observed  
α-glucosidase inhibitors. A counter-gradient was employed as make-up flow to keep the concentration 
of the organic modifier (methanol) constant, while the enzyme and substrate were added in a 1:1 ratio 
to a split flow from the HPLC effluent. Methanol concentrations below 30% did not have a significant 
effect on α-glucosidase activity, but 30% acetonitrile severely inhibited activity. No additives were 
used to increase resolution, but a PEEK reaction coil, controlled at 37 °C  and giving ca. 2 min reaction 
time, was employed. Two known compounds, (−)-epigallocatechin gallate (EGCG) and (−)-epicatechin 
gallate, present in pu-erh tea extract, were shown to have potential as α-glucosidase inhibitors. This 
method was also regarded as a potential quality control strategy for traditional Chinese medicine [42]. 
Angiotensin I converting enzyme (ACE), a dipeptidylcarboxypeptidase, forms part of an enzymatic 
system essential to the modulation of blood pressure and is therefore implicated in related diseases, 
e.g., hypertension, chronic cardiac failure, cardiac infarctions and diabetic nephropathy [62]. In this 
enzymatic system, renin converts angiogenin to angiotensin I which is then converted  by ACE to 
angiotensin II, a major vasoconstrictor. At the same time ACE also inactivates bradykinin, a vasodilator, 
which then leads to an increase in blood pressure [62]. ACE inhibitors thus have potential for the 
alleviation of these disease conditions. Van Elswijk et al. [10] developed a fluorescence method for the Int. J. Mol. Sci. 2012, 13                       
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detection of ACE inhibitors in milk hydrolysates. The HPLC effluent was split towards an ESI Q-TOF 
MS for quantification and tentative identification, the BCD system for detecting bioactives and a waste 
line. A fluorogenic substrate, o-aminobenzoic acid-phenylalanine-arginine-lysine-dinitrophenol-proline, 
was employed as it is cleaved by ACE to cause an increase in fluorescence and therefore an inhibitor 
would cause a decrease  in  fluorescence  [63]. Tween 20 (polyoxyethylenesorbitan monolaurate) as 
additive against non-specific binding and Tris buffer (pH 7.5) were employed. For increased sensitivity 
the ACE-containing mixture was allowed to interact with the HPLC effluent for 1 min in the first 
reaction coil, prior to the addition of the substrate. Thereafter, a second reaction coil was introduced 
allowing an additional reaction time of 2 min (Figure 2b). A fluorescence detector was used to monitor 
the biochemical reaction at excitation and emission wavelengths of 320 nm and 420 nm, respectively. 
PTFE knitted reaction coils were incubated at 50 °C  in an HPLC column oven while enzyme and 
substrate solutions, delivered by Superloops
, were maintained at 4 °C . The presence of 20 bioactive 
peptides with ACE inhibitory potential was observed in the milk hydrolysates tested. Identification of 
the peptides was based on their Q-TOF MS fragmentation profiles and comparison with a protein database.  
Rudzki et al. [64] reviewed the use of techniques hyphenating HPLC and gas chromatography with 
MS  to  search  for  ACE  inhibitors  based  on  chemical  structure.  By  combining  information  from  a 
myriad  of  publications  they  emphasized  the  importance  of  stereochemical  purity  of  synthesized 
inhibitors since (S)-stereo-isomers were active while (R)-stereo-isomers were not. The review was 
aimed at synthesized compounds and their metabolites in biological samples, but it did not include 
naturally occurring compounds or a biological detection step. 
Liver cytochrome P450s (CYPs) are involved in xenobiotic metabolism and are membrane bound 
enzymes that require nicotinamide adenine dinucleotide phosphate (NADPH) as electron donor for 
catalytic activity [65]. Making use of this requirement, Kool et al. [15] developed a classical EAD 
assay  with  β-naphtoflavone  (β-NF)  induced  rat  liver  microsomes  as  source  of  cytochrome  P450 
1A1/1A2 to investigate ligands without discriminating between inhibitors and activators. Conversion 
of  the  substrate,  epoxyresorufin,  by  CYP  1A1/1A2  to  resorufin,  a  fluorescent  compound,  in  the 
presence of NADPH, allows monitoring of the reaction by on-line fluorescence detection. Further 
optimization was performed in FIA mode with seven known ligands and provided concentration values 
needed to obtain 50% inhibition (IC50) comparable to the batch assay. Among the detergents (saponin, 
sodium cholate and Tween 20 and 80) and PEG polymers (PEG 6000 and 3325) tested, most improved 
the resolution of the assay, but only Tween 20 and 80 did not inhibit the activity of the microsomes. 
Superloops  were  used  to  deliver  the  substrate  with  Tween  20  and  β-NF  induced  microsomes, 
maintained  in  potassium  phosphate  buffer  (pH  7.4)  containing  sodium  chloride.  A  knitted  PTFE 
reaction coil with volume of 25 µL was incubated at 37 °C  in an instrument configuration similar to the 
schematic depiction in Figure 2b, but excluding the first coil. Methanol or acetonitrile could be used as 
organic solvents for HPLC separation with optimal concentrations of 3–6% and 1–3%, respectively.  
A make-up counter-gradient was added to the HPLC effluent to maintain organic solvent concentrations 
at the optimal level. The throughput of this assay was improved by splitting the HPLC effluent to 
parallel assays for CYP 1A (β-NF induced microsomes), CYP 2B (phenobarbital induced microsomes) 
and CYP 3A (dexamethasone induced microsomes) [43]. Known inhibitors were used for validation. 
Tween 20 was used as additive for the CYP 1A assay, but PEG 6000 was required for both the CYP 
2B and 3A assays due to tolerance issues. The substrates, epoxyresorufin (CYP 1A), pentoxyresorufin Int. J. Mol. Sci. 2012, 13                       
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(CYP  2B)  and  7-benzyloxy-4-trifluoromethylcoumarin  (CYP  3A),  were  monitored  using  separate 
fluorescence  detectors,  while  the  analytes  separated  by  HPLC  were  quantified  by  UV  detection.  
This  was  a  major  step  in  the  direction  of  higher  throughput  in  combination  with  high  resolution 
screening methods. 
A  further  development  was  the  replacement  of  microsomes  with  recombinant  supersomes 
expressing  only  human  CYP  1A2  [44].  Inhibitors  for  CYP  1A2  could  be  important  as  cancer 
prevention treatments, since this enzyme has been implicated as a bio-activator of carcinogens in heat 
processed meat and the conversion of herb alkenylbenzenes to carcinogenic 1'-hydroxymetabolites. 
Methoxyresorufin was employed as fluorogenic substrate and split flow was maintained with a mass 
rate attenuator which mixed small volumes of the HPLC effluent with the make-up flow comprising 
phosphate buffer. Optimization was first performed in batch assays to obtain the optimal methanol and 
NADPH  concentrations.  A  dual  syringe  pump  delivered  the  supersomes  and  NADPH/substrate 
mixtures separately into a PEEK reaction coil maintained at 37 °C , giving a reaction time of 3.3 min. 
IC50 values for known inhibitors and substrates were determined using FIA mode. Basil and kava kava 
extracts, known to contain alkenylbenzenes, were shown to contain inhibitors of CYP 1A2, indicating 
that potentially carcinogenic alkenylbenzene-metabolism could be reduced in herbal mixtures. Recently, 
Reinen et al. [45] used a fluorescence-based EAD assay with allyloxyresorufin as substrate to screen 
CYP BM3-mutant libraries for differences in affinity. This assay was very sensitive in terms of the 
ligands tested against the libraries and allowed structure-function analysis based on affinity. A recent 
general review on developments in search of plant bioactives by Van Beek et al. [66] also covered 
some of the new developments in on-line CYP EAD research.  
Glutathione-S-transferases (GST) form part of liver metabolism by conjugating glutathione (GSH) 
with  xenobiotics,  anticancer  drugs,  endogeneous  lipid  peroxidation  products,  prostaglandins  and 
electrophilic reactive intermediates [67]. GST could therefore be detrimental to cancer therapies by 
neutralizing anticancer drugs before they reach their targets. General GST inhibitors could be effective 
against cancer cells, but might also be lethal to normal cells which would then have diminished GST 
activity. However, GST P1 is known to be overexpressed in tumor cells and therefore could be a 
primary target for selective inhibitors without affecting metabolism in adjacent cells. A system similar 
to the parallel assay developed for CYP enzymes has been published for GST from rat liver cytosol 
(cGST) and recombinant human GST P1 expressed in Escherichia coli [16,43]. Substrates for both 
enzymes were monochlorobimane (MCB) and GSH which form GSH-bimane, a combined product 
with a strong fluorescent signal. Optimization, performed in batch assays, resulted in the selection of 
methanol as organic modifier for HPLC separation, PEG 6000 as additive to GSH and MCB, Tween 
20 as additive to the counter-gradient and 100 mM phosphate buffer (pH 6.5) as working buffer for the 
enzyme and substrate solutions. Reaction volumes for GST P1 and cGST were 500 µL and 75 µL, 
respectively. Superloops
 were used as delivery systems for enzymes and substrates to the HPLC 
effluent, knitted coils were incubated at 37 °C  and the reaction was monitored by fluorescence detection. 
IC50  values of  known inhibitors and some synthesized derivatives  as  determined  using  FIA mode 
correlated well with  results  from  the  batch  assay. The  experimental set-up allowed discrimination 
between general inhibitors, affecting cGST, and specific GST P1-inhibitors. Schebb et al. [46] modified 
the cGST system to investigate GSH adducts from the mycotoxin, patulin, for possible GST inhibition. 
Modifications  included  two  PEEK  reaction  coils  to  allow  interaction  between  enzyme  and  HPLC Int. J. Mol. Sci. 2012, 13                       
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effluent, and the reaction after addition of the substrate (Figure 2b). The reaction took place at 40 °C , 
while the HPLC effluent was monitored by UV and ESI-MS detection for quantification and tentative 
identification, respectively. Of the 15 patulin-GSH adducts,  the dihydro-parinone  adduct  with  one 
GSH moiety and a ketohexanoic acid with two GSH moieties showed marked inhibition. 
Proteases represent a large group of mammalian regulatory proteins with serine proteases being 
important  targets  for  antithrombotic  drugs  [68].  Serine  protease  inhibitors  were  investigated  by  
Schebb  et  al.  [47]  using  an  intricate  gradient-parking  system,  employed  to  maintain  a  constant 
concentration of the organic modifier, methanol, without the need for added make-up pumps. This 
system required the addition of a switching valve and two extra columns, one analytical and one 
preparative. It allows for the storage of a symmetrical gradient on the preparative column, which is 
then added as the make-up flow by switching the valve between analyses and reversing flow through 
the preparative column. Several gradients were tested as a characterization procedure for the parking 
system.  Candidate  serine  proteases,  thrombin  and  trypsin,  were  used  to  digest  the  substrate,  
H-D-cyclohexylalanine-Ala-Arg-7-amino-4-methylcoumarin, to release 7-amino-4-methylcoumarin, a 
fluorescent  compound.  Inhibitors  would  cause  a  decrease  in  fluorescence  relative  to  the  control. 
Superloops
 delivered the enzymes and substrates to the HPLC effluent. Enzymes and substrates were 
prepared in potassium phosphate buffer (pH 7.4) containing both PEG 6000 and ELISA blocking agent 
as additives. Two tandem PEEK reaction coils were used to first allow interaction between the HPLC 
effluent and enzymes prior to the addition of the substrate as shown in Figure 2b. IC50 values of known 
inhibitors, determined using FIA mode, were comparable with the results of batch assays. The system 
was finally validated by screening a small library of serine protease inhibitors.  
The same group investigated a system for the identification of proteases in mixtures of snake venom, 
from Bothrops moojeni, and an eye-infective amoeba, Acanthamoeba castellanii, which could have 
some importance in blood coagulation cascades [69]. Unlike the previously described EAD systems, 
this system focused on identification of active enzymes by adding a mixture of eight substrates, p-
nitroaniline labeled peptides, and monitoring the absorbance at 405 nm. However, it should be noted 
that  the  active  enzymes  can  then  be  used  in  conventional  EAD  systems  in  search  of  bioactive 
compounds, i.e., inhibitors or activators of proteases. The chromatographic step was also set up in 
buffer systems based on ion exchange or size exclusion chromatography to prevent inactivation or 
denaturation of possible proteases. No make-up flow and only one Superloop
, delivering the substrate 
mixture  to  a  knitted  fluorinated  ethylene  propylene  reaction  coil,  were  required.  Trypsin  and 
chymotrypsin were used as candidate proteases to set up and optimize the system, after which snake 
venom and supernatant from the amoeba homogenate were tested. Chromatographic separation of the 
BCD effluent was used in conjunction with ESI-MS/MS to measure the levels of the eight substrates in 
the mixture after the reaction coil and to investigate the selectivity of candidate proteases and fractions. 
The  active  fractions  from  both  samples  were  identified  and  could  be  collected  for  purification.  
A similar assay, aimed at the detection of human immunodeficiency virus (HIV)-protease inhibitors, 
was developed by coupling size exclusion chromatography with a BCD system [48,49]. Subtilisin was 
used as example protease. In this case fluorescence resonance energy transfer was employed as a 
detection method by using HIV-protease substrate 1, a peptide covalently bound to two chromophores, 
namely 5-[(2-aminoethyl)-amino]naphthalene-1-sulfonic acid and 4-(4-dimethylaminophenylazo) benzoic 
acid. The assay was tested with a mixture of inhibitors, aprotinin and 4-(2-aminoethyl)-benzenesulfonyl Int. J. Mol. Sci. 2012, 13                       
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fluoride hydrochloride, and with non-inhibitory compounds. IC50 values determined using FIA mode 
and on-line BCD were compared to those of batch assays. The assay could be performed in homogeneous 
mode (Figure 2b) due to the marked difference in fluorescence between substrate and product. 
When  cytochrome  c  is  subjected  to  proteolytic  digestion,  microperoxidases  are  formed. 
Microperoxidases retain the heme group of cytochrome c, but can have peptide chains of varying 
lengths, e.g., MP11 is a microperoxidase with a chain of 11 amino acids linked to the heme group. 
Microperoxidases  are  enzymes  used  in  analytical  chemistry  to  catalyze  the  oxidation  of  organic 
substrates by hydrogen peroxide [70]. Haselberg et al. [71] developed a dual substrate system for the 
detection of microperoxidases in proteolytic digests of cytochrome c. 4-(N-methylhydrazino)-7-nitro-
2,1,3-benzooxadiazole  is  converted  by  microperoxidases  to  4-(N-methylamino)-7-nitro-2,1,3-
benzooxadiazole, which fluoresces in the presence of hydrogen peroxide. Coupling this BCD system to 
reversed phase HPLC enabled identification of fractions with microperoxidase activity. MP11 was 
used as a model microperoxidase to optimize the system in terms of pH, acetonitrile concentration and 
buffer. The active fractions were identified by ESI-MS, using a reference library. MP6 was identified 
from the digest of bovine heart cytochrome c by proteases from Streptomyces griseus. Even though 
MP6  is  a  known  microperoxidase,  its  very  high  activity  indicated  potential  future  applications  in 
biosensors and chemiluminescence systems. It should be noted that these microperoxidases could also 
be  used  to  find  possible  bioactive  compounds  by  following  the  same  principles  as  discussed  for 
conventional EAD systems in this review. 
Phosphodiesterases  (PDE)  are  implicated  in  hypertension,  vascular  conditions  and  asthma.  The 
enzyme is responsible for hydrolysis of cyclic adenosine and guanosine 3',5' monophosphates (cAMP, 
cGMP) to AMP and GMP, respectively [72]. Due to a variety of isozymes which differ in substrate 
specificity, intracellular location, inhibitor specificity and regulation, it would be advantageous to find 
isozyme-specific  inhibitors.  Schenk  et  al.  [50]  developed  a  PDE-based  on-line  BCD  assay  with  
mant-cGMP as fluorescent substrate and 3-isobutyl-1-methyl-xanthine as known inhibitor during the 
validation phases using FIA mode. An evaporative light scattering detector was employed to quantify 
unknown  inhibitory  compounds  present  in  the  HPLC  effluent,  while  DAD  and  MS  were  used  to 
quantify known compounds for IC50 determinations, as well as for dereplication based on UV and MS 
spectra. The assay was monitored by fluorescence detection with peaks indicative of inhibitory activity. 
BSA at a concentration of 0.05% (w/v) was the most effective additive to increase the resolution of the 
assay. Final testing, performed on plant extracts spiked with known inhibitors, showed that low levels 
of  inhibitor  could  be  detected.  Kool  et  al.  [73]  developed  a  flow  through  assay  to  measure  the 
modulation of cAMP levels by G-protein coupled receptors based on fluorescence polarization (FP). 
The assay was coupled  to the cAMP binding domain of protein kinase A and fluorescein-labeled 
cAMP and tested against other nucleotides for sensitivity. This assay was proposed as an alternative to 
radioactive testing methods. 
A general on-line BCD assay for the detection of both phosphate consuming and releasing enzymes 
based  on  a  fluorophore,  phosphate  binding  protein  (PBP),  was  developed  by  Schenk  et  al.  [51]. 
Kinases and phosphatases are important drug targets involved in the transfer of phosphate. In FIA 
mode it could be used to measure the activity of phosphate releasing enzymes, but in chromatography 
mode with the enzyme added to the HPLC effluent, the assay could be effective in finding inhibitors 
for phosphate binding and releasing enzymes. Validation was performed with alkaline phosphatase as Int. J. Mol. Sci. 2012, 13                       
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an example of phosphate releasing enzymes and tetramizole, mixed with plant extract, as inhibitor. 
Hyphenation with TOF-MS provided information for identification of inhibitors, whereas fluorescence 
detection was used to detect inhibitors, observed as negative peaks. A powerful advantage of this 
particular assay is that the PBP could distinguish between free phosphates released by enzymes and 
bound phosphates forming part of many physiological compounds.  
Falck  et  al.  [52]  developed  a  BCD  assay  to  investigate  small  molecule  inhibitors  of  p38α  
mitogen-activated protein (MAP) kinase. Inhibitors of MAP-kinases are primary drug targets as they 
are implicated in inflammatory response cascades [74]. The on-line p38α MAP-kinase affinity assay 
was used in parallel with a high resolution ESI ion trap (IT) TOF-MS system to enable very accurate 
identification  of  small  binding  molecules.  This  system  was  similar  to  the  system  used  by  de  
Vlieger et al. [8] for their investigation into ligands for both estrogenic receptors α and β, as discussed 
in more detail in Section 3.2. Furthermore, Falck et al. [52] classified MAP kinase inhibitors into  
4  groups  according  to  binding  specificity:  (1)  type  I  binding  only  to  the  adenosine  triphosphate  
(ATP)-binding site; (2) type II binding to both the ATP-binding site and an allosteric binding site in 
close proximity; (3) type III binding only to the allosteric site and (4) type IV binding to neither of 
these sites. The fluorescent tracer-ligand, SK&F86002 (SKF), used for detection, was a type I inhibitor 
which showed a marked increase in fluorescence upon binding to MAP-kinases. This allowed for a 
homogeneous configuration in this HPLC-EAD assay. Competing ligands would cause a decrease in 
fluorescence which would be observed as negative peaks in the secondary detector. The system was 
optimized for reaction temperature (25 °C ), tracer concentration at saturation, formic acid  content 
(0.01%)  in  the  HPLC  effluent  and  the  reaction  coil  material,  i.e.,  polar  covalently  modified  
(PEG-coated)  fused  silica  tubing.  Rigorous  testing  procedures  showed  this  system  to  be  very 
reproducible which enabled its application in a semi-quantitative manner. Even though IC50 values for 
known inhibitors, calculated using this system, was considerably lower than those calculated in batch 
assays, the ranking of these inhibitors still followed a similar trend as observed with the batch assays. 
Finally, their system proved sensitive enough to detect inhibitors of not only type I (TAK 715, MAP 
kinase inhibitor I) and type II (BIRB796), as both types involve the ATP-binding site directly, but also 
of type III inhibitors (pyrazolourea) that causes conformational changes in the ATP-binding site upon 
binding to the allosteric site. 
3.2. RAD Assays 
Estrogen  receptors  are  not  only  prime  targets  for  hormone  replacement  therapies  and  
subsequent anti-cancer investigations [11], but they are also targeted as a means of detecting endocrine 
disruptors [75]. Phytoestrogens are touted as possible alternatives to hormone replacement therapies 
without the side effects. To this end, Oosterkamp et al. [53] developed a RAD assay with recombinant 
human estrogen receptor steroid binding domain coupled to HPLC. Coumestrol was used as ligand, 
resulting  in  a  major  increase  in  fluorescence  when  it  binds  to  the  estrogen  receptor  (ER). 
Phytoestrogens could be detected in homogeneous or heterogeneous mode, where unbound coumestrol 
is  retained  on  a  restricted  access  column.  In  the  chromatography-linked  assay,  the  homogeneous 
configuration was used to prevent regeneration of the restricted access column by the organic modifier 
in the HPLC effluent. A dual knitted PTFE coil system was employed where the HPLC effluent was Int. J. Mol. Sci. 2012, 13                       
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allowed to interact with the ER in the first coil and unbound ER to bind to coumestrol in the second 
coil at room temperature (Figure 2b). A mixture of seven human steroids (17-β-estradiol, progesterone, 
estrone, methyltestosterone, estriol, zeranol, diethylstilbestrol) was used as validation system for assay 
specificity  and  calculation  of  detection  limits.  Progesterone  and  17-β-estradiol  demonstrated  the 
selectivity of the assay with progesterone not bound by the ER. The hydroxyl group of 17-β-estradiol 
that forms the recognition site for the ER is replaced with a carbonyl group in progesterone. The ER 
also did not bind methyltestosterone, as expected. Detecting 17-β-estradiol in spiked urine samples 
showed the applicability of this technique for future drug testing of athletes. This assay was also used 
as  an  illustration  in  two  reviews  on  the  theoretical  aspects  of  ligand  based  HPLC  on-line  BCD  
assays [24] and xenoestrogens and endocrine disruptors [75], respectively. 
Schobel et al. [11] developed the assay further to distinguish between ERα and ERβ. Coumestrol 
was still used as fluorescent ligand and the assay was set up in a homogeneous conformation. FIA 
mode and batch assays were used to screen for most active extracts from their library of plant extracts. 
Only  the  most  active  extracts  were  tested  on  the  BCD  system  and  ESI-MS  was  used  to  identify 
estrogenic  compounds  for  which  IC50  values  were  calculated.  Using  the  IC50  values  the  binding 
affinities relative to 17-β-estradiol were calculated for identified compounds. Van Elswijk et al. [76] 
analyzed acid hydrolyzed pomegranate peel extracts for ERβ agonists and showed that the flavonoids, 
luteolin, quercetin and kaempferol, had agonistic properties. Due to an 80 s assay time with subsequent 
band broadening, highly concentrated extracts were analyzed and ELISA blocking reagent was used to 
prevent  non-specific  binding.  Van  Liempd  et  al.  [13,30]  combined  metabolism  assays  and  ER 
screening which is described in more detail in section 3.3. Kool et al. [54] used an analogous method 
to that of Oosterkamp et al. [53] to investigate pig and rat liver microsomal metabolites of tamoxifen 
and (Z)-4-hydroxytamoxifen for ERα affinity. Most of the 14 metabolites displayed various degrees of 
affinity  for  ERα.  Reinen  et  al.  [55]  developed  an  ERα  assay  based  on  FP  detection  allowing 
fluorescence measurement at higher wavelengths. Fluorescence detection at these higher wavelengths 
negated the interference of auto-fluorescence of investigated compounds. A specific fluorescein-labeled 
estradiol derivative was synthesized as probe and the system optimized for detection purposes using a 
mixture of five known estrogenic compounds in FIA mode. De Vlieger et al. [8] performed a parallel 
assay  for  both  human  ERs  on  the  metabolites  of  six  estrogenic  compounds,  natural  estrogen  
(17-α-estradiol  and  17-β-estradiol),  synthetic  ER  modulators,  prodrugs  (17-α-ethinylestradiol  and 
norethisterone),  and  synthetic  compounds  from  the  Schlering-Plough  library  (ORG-X,  ORG-Y). 
Estrogenic compounds were subjected to metabolism by human liver microsomes and mutant bacterial 
CYPs. Out of 85 metabolites, 55 hits on one or both ERs were detected and consisted of mostly 
hydroxylated or dihydroxylated and some dehydrogenated metabolites. ESI-MS was used for tentative 
structure elucidation, while preparative scale isolation of norethisterone metabolites enabled further 
structure  elucidation  by  NMR.  From  these  structures  they  could  elucidate  patterns  of  preferable 
metabolism sites on these compounds. 
The urokinase plasminogen activator receptor (uPAR) is a multifunctional protein playing key roles 
in cellular adhesion and migration and is believed to regulate cellular responses during angiogenesis, 
inflammation, wound repair, and tumor metastasis [77]. Oosterkamp et al. [12] developed a RAD 
system for uPAR by synthesizing a solubilized fluorescent labeled uPAR. The proteolytic enzyme, 
urokinase plasminogen activator (uPA), was employed as a model protein to show the applicability of Int. J. Mol. Sci. 2012, 13                       
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this RAD technique. Optimization was performed using FIA mode. No make-up flow was required and 
Tween 20 was used as additive in an assay performed at room temperature with a reaction time of 60 s. 
A specially designed affinity column was applied downstream of the reaction coil in heterogeneous 
mode  to  retain  unbound  receptor,  as  the  receptor  fluoresced  in  both  bound  and  unbound  states  
(Figure 2c). Hence, peaks on the fluorescence chromatogram were indicative of ligands bound to the 
uPAR. Plasma samples were analyzed for ligands of uPAR and active metabolites, but other complex 
matrices could in all probability be screened with this assay in search of therapeutic compounds of 
natural origin. This assay was set up as a model for similar types of assays to provide alternative 
methods to immunochemical assays which are less specific. 
3.3. Application of EAD and RAD Assays in Metabolic Profiling Assays  
Metabolite  profiling  systems  are  set  up  in  a  pre-chromatography  configuration  often  including  
on-line SPE connected to HPLC (Figure 2d). Van Liempd et al. [29] developed a CYP 1A1/1A2  
bio-reactor system with β-NF activated liver microsomes and ethoxyresorufin as fluorogenic substrate. 
The system, optimized for reaction temperature (37 °C ), choice of SPE and substrates, included a 
PEEK  filter  to  prevent  blockages  of  the  chromatographic  system.  Validation  of  the  assay  was 
performed by repeated analysis of the reaction products using a fluorescence detector. Regeneration of 
the SPE column and the filter device was performed with relative ease, which showed this to be a 
potentially valuable application for metabolite analysis. 
The power of this assay was emphasized by two subsequent publications by the same authors, 
where the CYP bioreactor system was coupled to  an ERα BCD assay to detect bioactivity of the 
metabolites. Two known selective estrogen receptor modulators, tamoxifen and raloxifene, metabolized 
by the CYP bioreactor system and analyzed for ERα affinity led to the identification of 15 active 
tamoxifen metabolites and six active raloxifene metabolites [13]. MS/MS analysis of the metabolites 
yielded more information, enabling identification of three novel raloxifene metabolites with activity. 
The CYP bioreactor system was also optimized for metabolites of endocrine disrupting compounds 
(EDCs) with an emphasis on xenoestrogens and their affinity for ERα [30]. Methoxychlor was used as 
candidate  EDC  with  its  metabolites,  mono-  and  bis-hydroxymethoxychlor.  Following  successful 
optimization, the metabolism of 2-hydroxy-4-methoxy-benzophenone was investigated, resulting in 
three active metabolites with at least one novel hydroxyl metabolite. Even though this system was set 
up as a RAD assay for the detection of bioactive metabolites, it could also be used in conjunction with 
EAD or on-line antioxidant assays.  
Recently,  a  biochip  method  using  precision  cut  liver  slices  and  a  micro-fluidic  technique  was 
developed as alternative to microsomal assays [31]. The biochip system was not only stable under 
perfused conditions over a 24 h period, but it has several advantages, mainly because it contains whole 
cells  and  fully  intact  enzyme  systems.  The  biochip  system  was  tested  with  two  substrates,  
7-hydroxycoumarin and diclophenac, and one inhibitor, phloxine B, for which IC50 values could be 
calculated and thermo-unstable metabolites detected. In future this system might be coupled to an 
RAD, EAD or on-line antioxidant system to detect the bioactivity of drug metabolites resulting from 
liver biochips. Int. J. Mol. Sci. 2012, 13                       
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4. HPLC Coupled to On-Line Antioxidant Detection 
HPLC on-line antioxidant assays have seen increasing application during the past few years for the 
investigation of plant extract constituents responsible for antioxidant activity. These assays can be 
classified, based on the principle of the assay, i.e.: (1) assays based on reaction with a stable oxidizing 
reagent; (2) assays based on reaction with a physiologically-relevant reactive oxygen species (ROS); 
and (3) assays based on electrochemical measurements. In the first type of assay, reaction of a stable 
oxidizing reagent with the antioxidant results in a measurable change (e.g., absorbance decrease or 
increase at a specific wavelength). The second type of assay uses an oxidizing agent which is also 
present  in  biological  systems,  i.e.,  ROS  such  as  superoxide  radical  anions  or  hydrogen  peroxide.  
The ROS  is  able to  oxidize a substrate, of which the  concentration  can be measured (e.g.,  using 
chemiluminescence). When an antioxidant counteracts the oxidation of the substrate, the change in 
concentration of unoxidized substrate can be measured. The third type of assay is based on the direct 
measurement of electron transfer from the antioxidant to an electrode, with both the measured potential 
and current providing information. HPLC on-line antioxidant assays were recently reviewed in detail by 
Niederlä nder et al. [78]. This section will aim to summarize the main findings of Niederlä nder et al. [78] 
with  regard  to  the  first  two  types  of  on-line  antioxidant  assays  and  will  include  methodological 
improvements  and  applications  since  2008.  On-line  antioxidant  assays  based  on  electrochemical 
detection will not be covered in this review, as the focus is on post-column reaction with reagents 
aimed at detecting bioactivity of separated compounds.  
4.1. On-Line Antioxidant Assays Based on Stable Oxidizing Reagents 
On-line  antioxidant  assays  using  stable  oxidizing  reagents  are  generally  simple  and  easy  to  
handle  compared  to  assays  involving  physiologically-relevant  ROS.  The  basic  instrumental 
configuration  is  the  same  for  all  antioxidant  assays  (Figure  2a).  The  only  variation  between  
assays  is  in  the  number  of  reagents  added  to  the  HPLC  effluent.  The  most  widely  used  assays  
of  this  type  involve  the  stable  free  radicals,  1,1-diphenyl-2-picrylhydrazyl  radical  (DPPH
•)  and  
2,2'-azinobis-(3-ethylbenzothiazoline-6-sulfonate)  radical  cation  (ABTS
•+),  which  are  scavenged  by 
antioxidants, resulting in a decrease in absorbance observed as negative peaks. Recently, an on-line 
radical scavenging assay, employing galvinoxyl radicals, has also been described [79]. Additionally, 
assays  based  on  the  redox  reaction  of  antioxidants  with  a  phosphomolybdate  reagent  [80],  
Folin-Ciocalteau reagent [81,82] and Cu(II)-neocuproine reagent [83], used in the cupric reducing 
antioxidant capacity (CUPRAC) batch assay, have been reported. An HPLC-chemiluminescence (CL) 
assay  based  on  CL  of  acidic  permanganate  has  also  been  reported  [84–86],  indicating  reducing 
capacity of the antioxidants detected. In the latter four assays, the antioxidant compounds are detected 
as positive peaks due to formation of a colored product after reaction of the antioxidant with the 
reagent. Table 2 provides a comparison of several important aspects for each type of assay. 
The  first  HPLC-DPPH  assay,  using  a  methanolic  solution  of  DPPH
•,  was  described  by  
Koleva et al. [5]. The antioxidant compounds were detected as negative peaks at 517 nm. The DPPH
• 
concentration  was  optimized  and  the  effect  of  reaction  time,  mobile  phase  composition  and  pH 
investigated. A reaction time of 30 s was chosen as optimum and the assay deemed applicable for Int. J. Mol. Sci. 2012, 13                       
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gradient  elution  with  a  mobile  phase  composition  varying  between  10  and  90%  organic  modifier 
(methanol or acetonitrile) and pH 3 to 6. 
Table  2.  Comparison  of  on-line  antioxidant  assays  based  on  reaction  with  a  stable 
oxidizing reagent. 
Assay 
Reaction 
Mechanism 
Detection  Reagent Solution Characteristics  HPLC Mobile Phase Compatibility 
DPPH
• scavenging 
[5,79,87,88] 
H-donation 
UV-VIS, 
510–520 nm 
DPPH
• in MeOH or MeOH/buffer 
(pH 7.6) mixture for RP-HPLC;  
n-hexane for NP-HPLC 
10–90% organic modifier at pH 3–6 
a for 
RP-HPLC; gradient of n-hexane and 
isopropanol for NP-HPLC 
ABTS
•+ scavenging 
[88,89] 
e
−-transfer 
UV-VIS, 
410–430, 
630–640, 
734 nm 
ABTS
•+ in buffer or MeOH/buffer 
mixture (pH 7.4or 7.6) for  
RP-HPLC; MeOH for NP-HPLC 
0–100% organic modifier at pH 3–7.4 
(TFA not recommended) for RP-HPLC; 
gradient of n-hexane and isopropanol for 
NP-HPLC 
Galvinoxyl
• 
scavenging [79] 
H-donation 
UV-VIS, 
425 nm 
Galvinoxyl
• in 100% n-hexane  
or MTBE 
Suitable for NP-HPLC using gradient of 
n-hexane and MTBE 
Phosphomolybdate/ 
Folin-Ciocalteau 
reagent [80–82] 
e
−-transfer 
UV-VIS, 
598, 750 nm 
Phosphomolybdate/Folin-Ciocalteau 
reagent in acidic aqueous solution 
Suitable for use with most RP-HPLC 
solvents; <80% organic modifier to 
prevent precipitation of salts; not suitable 
for NP-HPLC as reagent not soluble in 
100% organic mobile phase 
CUPRAC reagent 
[83] 
e
−-transfer 
UV-VIS, 
450 nm 
Cu(II)-neocuproine in ammonium 
acetate buffer (pH 7) 
Suitable for use with most RP-HPLC 
solvents; not suitable for NP-HPLC as 
reagent not soluble in 100% organic 
mobile phase 
Acidic KMnO4 
reagent [84–86,90] 
unknown  CL 
KMnO4 and Na polyphosphate or  
Na hexametaphosphate (enhancer) 
solution, adjusted to pH 2 or 2.3  
with H2SO4 
Acidified aqueous phases combined with 
MeOH gradients; MeCN not 
recommended due to CL quenching 
a  lower  pH  mobile  phases  can  be  used  when  buffering  the  reagent  solution;  ABTS,  2,2'-azinobis-(3-
ethylbenzothiazoline-6-sulfonate); CL, chemiluminescence; CUPRAC, cupric reducing antioxidant capacity; 
DPPH, 1,1-diphenyl-2-picrylhydrazyl; MeCN, acetonitrile; MeOH, methanol; MTBE, methyl tert-butyl ether; 
NP-HPLC,  normal  phase  high  performance  liquid  chromatography;  RP-HPLC,  reversed  phase  high 
performance liquid chromatography; TFA, trifluoroacetic acid. 
Mobile phases at lower pH caused a dramatic loss of sensitivity due to a decrease in absorbance of 
DPPH
•. Reaction temperature was not controlled. The reaction kinetics of compounds was considered 
to play a role as exemplified by differences in minimum detectable amounts for antioxidants known to 
be fast (quercetin; 6.6 ng) or slow (eugenol; 1.9 μg) DPPH
• scavengers. Dapkevicius et al. [87] improved 
the sensitivity up to 30-fold by adding citric acid-phosphate buffer at pH 7.6 to the methanolic reagent 
solution combined with degassing of the reagent solution, addition of a pulse damper and an increased 
reagent flow rate. Buffering of the reagent solution decreased the effect of acidic mobile phases. The 
reaction mechanism of the HPLC-DPPH assay was revisited by Bartasiute et al. [91], who showed that 
the presence of water in the mobile phase has a significant effect on the reaction kinetics compared to a 
pure methanol medium, mostly used in batch assays. The reaction of DPPH
• with an antioxidant is Int. J. Mol. Sci. 2012, 13                       
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characterized  by  slow  kinetics  going  to  completion  in  methanol,  while  a  dynamic  equilibrium  is 
established rapidly in the presence of water. This explains why several HPLC-DPPH applications use 
reaction times of less than 10 s compared to reaction times of 30 min to 2 h generally used in batch 
assays [84,91,92]. Bartasiute et al. [91] was also the first group to adopt a quantitative approach by 
calculating  Trolox  equivalent  antioxidant  capacity  (TEAC)  values  for  the  antioxidant  compounds, 
while thermodynamic equilibrium constants were also determined. Calculation of TEAC values were 
also reported by Arthur et al. [93], while De Beer et al. [4] calculated the antioxidant activity of 
hydroxycinnamic acid derivatives relative to that of caffeic acid. Most applications follow the protocol 
of either Koleva et al. [5] or Dapkevicius et al. [87] with minor modifications in terms of dimensions 
of the reaction coil, reagent flow rate and method of reagent solution delivery (syringe pump or HPLC 
pump) (as reviewed by Niederlä nder et al. [78]). A number of applications with modified methodology 
or novel approaches will be highlighted in the following text. 
Application of the HPLC-DPPH assay using different buffers, such as citric acid-sodium citrate at 
pH 7.6 [94] or MES buffer at pH 6 [95], and higher temperatures, i.e., 60 °C  [84,95], has been reported. 
The HPLC-DPPH assay has been hyphenated with MS [79,96–102] and SPE-NMR [103,104] analysis 
by splitting the HPLC effluent before the on-line antioxidant reaction coil. He et al. [88] also applied 
the assay using normal phase HPLC (NP-HPLC) to identify non-polar tocopherols with antioxidant 
activity in a supercritical fluid extract of Gardenia fruit oil. Zhang et al. [79], on the other hand, 
investigated the use of NP-HPLC with on-line DPPH
• scavenging detection, but decided to rather use 
the galvinoxyl radical due to better signal-to-noise ratios. In both these cases, the reagent was prepared 
in  hexane.  Other  novel  applications  include  optimization  of  the  assay  for  use  with  commercially 
available  derivatization  equipment  [81,82]  and  use  of  the  technique  to  obtain  information  on  the 
antioxidant activity and the position of conjugation for hepatic phase II metabolites of aspalathin [105]. 
The first HPLC-ABTS assay was also developed by Koleva et al. [89], where antioxidant compounds 
were detected as negative peaks at 734 nm after reaction with the ABTS
•+ reagent in a reaction coil 
giving a reaction time of 30 s. The reagent was prepared in 10% methanol in phosphate buffered saline 
(pH 7.4). The method was suitable for use with isocratic or gradient HPLC from 0 to 100% organic 
modifier at pH 3 to 7.4. The method was also optimized in terms of reagent concentration and reagent 
flow rate. The method proved to be more sensitive and more suitable for detection of water-soluble 
antioxidants than their HPLC-DPPH assay developed earlier [5]. Cano et al. [106] applied the method 
with  minor  modifications,  namely  preparation  of  the  reagent  using  horse  radish  peroxidase  and 
hydrogen peroxide, different coil dimensions and detection at 600 nm, while stressing the importance 
of a reaction time of at least 1 min to achieve complete reaction of all antioxidants. Detection is possible 
at various wavelengths due to multiple peaks in the spectrum of ABTS
•+ [107]. Cano et al. [106] 
determined TEAC values for a range of antioxidants from hydrophilic (e.g., ascorbic acid) to lipophilic 
(e.g.,  tocopherols)  antioxidants.  TEAC  values  were  also  calculated  by  Stewart  et  al.  [108]  and  
He et al. [109], while De Beer et al. [4] calculated antioxidant values equivalent to caffeic acid for 
several hydroxycinnamic acid derivatives (HPLC-BCD chromatogram shown in Figure 1). Hyphenation 
of HPLC-ABTS with MS [110] and SPE-NMR [104,111] detection has also been reported. Novel 
methodology or modifications  applied since 2008 include the following:  NP-HPLC using ABTS
•+ 
reagent prepared in phosphate buffered saline and diluted with methanol [88]; reaction temperature of 
40 °C  [108,112,113]; method validation [114]; assessment of the activity and position of conjugation Int. J. Mol. Sci. 2012, 13                       
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for hepatic phase II metabolites of aspalathin [105]; and use of a commercially available derivatization 
equipment [81,82]. 
The  only  report  of  an  on-line  antioxidant  assay  employing  galvinoxyl  radicals  is  that  of  
Zhang et al. [79] using NP-HPLC hyphenated with MS detection. The assay parameters, i.e., reagent 
concentration, reagent solvent composition, flow rate and coil length, were optimized. A Superloop
 
was employed for delivery of the reagent in hexane, which markedly increased the signal-to-noise ratio 
compared to reagent delivery using an HPLC pump. The method was applied to detect antioxidant 
tocopherols in wheat germ oil and olive oil, while carnosic acid, carnosol and an as yet unidentified 
compound were shown to be the major non-polar antioxidants in an oil-soluble rosemary extract.  
Cardeñ osa  et  al.  [80]  were  the  first  to  report  an  HPLC  on-line  antioxidant  assay  involving  a 
phosphomolybdate reagent. No other reports mentioning this technique have been forthcoming until 
recent reports of an on-line antioxidant assay involving the related Folin-Ciocalteau reagent containing 
heteropolyphosphotungstates-molybdates [81,82]. Both these assays are believed to share a similar 
reaction mechanism involving electron-transfer from an antioxidant compound reducing Mo
6+ to Mo
5+ 
to form a blue-green complex detected at wavelengths higher than 580 nm [80,115]. High temperatures, 
i.e.,  95  °C   and  130  °C ,  for  the  phosphomolybdate  and  Folin-Ciocalteau  reagents,  respectively, 
shortened the reaction time needed. The main technical difference between the assays involves the  
use  of  the  commercially  available  Folin-Ciocalteau  reagent  and  derivatization  instrument  by 
Kusznierewicz  et  al.  [81,82]  compared  to  the  preparation  of  the  reagent  and  the  built-to-purpose 
reactor used by Cardeñ osa et al. [80].  
Cardeñ osa  et  al.  [80]  optimized  several  parameters  of  their  HPLC-phosphomolybdate  assay,  
i.e.,  HPLC  flow  rate,  reagent  flow  rate,  sodium  phosphate  concentration,  ammonium  molybdate 
concentration, sulfuric acid concentration and reaction temperature. The method was then applied to 
detect  antioxidants,  as  well  as  to  quantify  tocopherol.  Several  tocopherols  and  carotenoids  were 
identified as antioxidants in hexane extracts from lettuce, tomato, red pepper and soybean seed. The 
validated method for the quantification of tocopherols was shown to be more sensitive than a HPLC 
method with fluorescence detection. The reaction of antioxidants with the phosphomolybdate reagent 
is compatible with buffers and solvents normally used as HPLC mobile phases [116]. Interestingly, a 
reduction of reaction temperature to 27 °C  in the on-line assay [80] or 37 °C  in the batch assay [116] 
permitted some selectivity based on the nature of the antioxidant. At lower temperatures, only strong 
antioxidants showed a response. 
The  HPLC-Folin-Ciocalteau  assay  was  also  optimized  in  terms  of  reagent  concentration  and 
reaction temperature [81,82]. At the very high temperatures used in the assay (130 °C ), some concern 
existed about the stability of antioxidant compounds during the assay (reaction time < 1 min), but no 
degradation was detected. Precipitation of salts in the Folin-Ciocalteau reagent was a problem when 
the reagent concentration was higher than 50% or the HPLC mobile phase contained more than 80% 
methanol. The presence of formic acid did not affect the stability of the reagent, although it affected 
the antioxidant activity of resveratrol compared to the batch assay. The optimized on-line assay was 
subsequently  employed  to  determine  TEAC  values  for  mixtures  of  authentic  standards  including 
ascorbic acid and several phenolic compounds. The values were lower than those of the batch assay, but 
a strong correlation (>0.85) was observed between values obtained with the on-line and batch assays. 
Several antioxidant compounds were also identified in chokeberry, sloe and Mirabelle plum extracts. Int. J. Mol. Sci. 2012, 13                       
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The HPLC-CUPRAC assay, developed by Çelik et al. [83], makes use of electron-transfer from an 
antioxidant to the Cu(II)-neocuproine reagent resulting in its reduction to Cu(I)-neocuproine, which 
has an absorption maximum at 450 nm. The reaction of antioxidants with the CUPRAC reagent is 
reported to be unaffected by changes in solvent composition [117]. Apak et al. [118] also stated that 
the reaction is ―relatively insensitive to a number of parameters, for example, air, sunlight, humidity, 
and pH to a certain extent‖, although no data were shown to this effect. The CUPRAC reagent reacts 
rapidly with some compounds (< 20 min for complete reaction with amongst others ascorbic acid, 
gallic acid, ferulic acid and quercetin), but reactions with other compounds were slow (>20 min for 
complete reaction with naringin, naringenin and EGCG) [83,118,119]. Antioxidants with slow reaction 
kinetics  may  not  be  detectable  using  the  on-line  CUPRAC  assay  due  to  the  short  reaction  time  
(<1 min). The on-line CUPRAC assay was successfully applied for the detection of antioxidants in 
Camellia sinensis (gallic acid and several flavan-3-ols), Origanum marjorama (hydroxycinnamic acids, 
flavonols  and  flavone  aglycones)  and  Mentha  (rosmarinic  acid  and  flavone  aglycones)  
extracts [83]. Very little band-broadening was observed, presumably due to the short reaction time 
using a coil with  narrow-bore tubing.  Very low limit  of detection values  were obtained due  to  a  
low noise level. Some baseline drift was observed in the area of the chromatogram corresponding to a 
high  concentration  of  organic  solvent,  but  this  could  be  taken  into  account  by  subtracting  a  
blank chromatogram. 
HPLC-CL detection of antioxidants based on an acidic potassium permanganate system has been 
described recently [84–86,90]. The exact mechanism for redox reaction between permanganate and 
antioxidant compounds at low pH is not yet clear [120], but the reaction results in light emission due to 
an electronically excited Mn(II) species. Antioxidants are therefore detected as positive peaks in the 
HPLC-CL  chromatogram  based  on  their  reducing  capacity.  Sodium  polyphosphate  or  sodium 
hexametaphosphate is added as CL enhancer in the reported assays. The reaction is extremely rapid 
needing  no  reaction  coil,  which  is  a  prerequisite  for  other  on-line  antioxidant  assays.  The  CL  is 
detected  immediately  after  mixing  of  the  HPLC  effluent  with  the  acidic  potassium  permanganate 
reagent using a flow-through luminometer. The experimental set-up is, therefore, much simpler and 
cheaper than other on-line antioxidant assays. Parameters such as reagent and enhancer concentration, 
pH and flow rate were optimized to obtain the best CL response [86]. The only drawback of the 
method is that the CL signal is significantly quenched by acetonitrile, dictating the use of methanol 
gradients. Acidification of the aqueous HPLC mobile phase did not have a significant effect on the 
signal  intensity.  Interesting  applications  using  this  method  include  parallel  detection  of  DPPH
• 
scavenging activity and CL after splitting the HPLC effluent [84], as well as two dimensional HPLC 
hyphenated to CL detection of antioxidant compounds [85]. 
4.2. On-Line Antioxidant Assays Based on Physiologically-Relevant ROS 
Most assays based on physiologically relevant ROS rely on CL at 425 nm produced by oxidation of 
luminol (5-amino-2,3-dihydrophthalazine-1,4-dione) to 3-aminophthalate (Figure 3) [121]. Luminol 
can be oxidized by hydrogen peroxide and/or superoxide radical anion depending on the ROS generation 
system  used  [78].  A  catalyst,  such  as  various  enzymes,  metalloproteins,  metal  ions  or  metal  ion 
complexes, is needed for the reaction [122]. Antioxidant compounds cause a decrease in CL due to Int. J. Mol. Sci. 2012, 13                       
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scavenging of the ROS or interference with the oxidation of luminol, although in some cases inhibition 
of an enzyme, which produces the ROS or acts as a catalyst, can also play a role [78]. 
Figure 3. Reaction mechanism for the oxidation of luminol (5-amino-2,3-dihydrophthalazine-
1,4-dione) to produce chemiluminescence (adapted from Rose & Waite [123]). 
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As most mechanisms involved in CL quenching in the HPLC-CL assays are related to an aspect of 
antioxidant activity, activity in these assays should be seen as an indication of the general electron 
donating ability of an antioxidant. Many HPLC-CL assays  based on luminol oxidation have been 
reported for the detection of compounds without reference to their antioxidant activity as reviewed by 
Gá miz-Gracia et al. [124]. The present review, however, will focus solely on applications specifically 
developed  for  detection  of  antioxidant  compounds.  Applications  involving  ROS,  but  not 
chemiluminescence, have also been reported. A rather complex system detecting both antioxidants and 
pro-oxidants (termed pro-oxidant and antioxidant detection, PAD) was reported by Kool et al. [9].  
On-line antioxidant assays based on physiologically-relevant ROS are summarized in Table 3 in terms 
of ROS  generation system,  detection and probable mechanisms  involved, as  well as  suitability of 
HPLC mobile phases. HPLC-CL assays generally follow the instrumental configuration depicted in 
Figure 2a, but with the addition of a second pump delivering a second reagent before the reaction coil 
for most of the published assays. 
The  first  HPLC-CL  method  developed  specifically  for  detection  of  antioxidant  compounds  by 
Dapkevicius  et  al.  [125]  used  hydrogen  peroxide  as  oxidant  and  MP11  as  catalyst  for  luminol 
oxidation at pH 10. The method was successfully applied to identify antioxidant compounds in sage 
and thyme extracts using gradient elution. A similar method using only luminol and hydrogen peroxide 
at pH 8 was reported by Toyo’oka et al. [126]. Ding et al. [127] used a system similar to that of 
Dapkevicius et al. [125], but ethylenediaminetetraacetic acid was included in the reaction mixture, 
presumably to prevent interference by iron. These assays purport to detect antioxidant compounds 
mainly on the basis of hydrogen peroxide scavenging activity, although other mechanisms may play a 
role as highlighted above. Int. J. Mol. Sci. 2012, 13                       
 
 
3122 
On-line  detection  of  compounds  with  superoxide  radical  anion  scavenging  activity  has  been 
performed  using  a  hypoxanthine/xanthine  oxidase  system  in  the  presence  of  catalase  to  prevent 
participation of hydrogen peroxide in the reaction [126,128]. 
Table 3. Summary of on-line antioxidant assays based on physiologically relevant reactive 
oxygen species (ROS). 
Assay 
Reaction 
Mechanism 
Detection  Reagent Solution Characteristics 
HPLC Mobile Phase 
Compatibility 
Assays based on H2O2 scavenging 
HPLC-CL 
H2O2/MP11/ 
luminol [125] 
Oxidant: H2O2; 
Catalyst: MP11; 
Emitter: luminol 
oxidation product 
CL,  
425 nm 
Reagent 1: MP11 and luminol in 
30% methanol/buffer (pH 10); 
Reagent 2: aqueous H2O2 
No addition of acidifier; 
acetonitrile content ≥ 30% 
HPLC-CL 
H2O2/luminol 
[126] 
Oxidant: H2O2; 
Emitter: luminol 
oxidation product 
CL 
Reagent 1: luminol in 10% 
methanol/buffer (pH 8);  
Reagent 2: aqueous H2O2 
Isocratic elution with MeOH/1% 
H3PO4 (28/71); eluent neutralized 
before addition of CL reagents 
HPLC-CL 
H2O2/EDTA/ 
luminol [127] 
Oxidant: H2O2; 
Emitter: luminol 
oxidation product 
CL 
Reagent 1: luminol and EDTA in 
buffer (pH 10);  
Reagent 2: aqueous H2O2 
0.1% H3PO4 aqueous phase 
combined with MeCN gradient  
< 65%; higher acid concentration 
or MeOH gradient caused 
baseline drift 
Assays based on O2
•− scavenging 
HPLC-CL 
HX/XOD/catalase/ 
K3Fe(CN)6/ 
luminol [128] 
Oxidant: O2
•− 
(HX/XOD/catalase) 
Catalyst: K3Fe(CN)6; 
Emitter: luminol 
oxidation product 
CL 
Reagent 1: HX and luminol in 10% 
methanol/buffer (pH 8); 
Reagent 2: aqueous K3Fe(CN)6; 
Reagent 3: XOD and catalase in 
buffer (pH 8) 
No addition of acidifier; 
MeOH/water gradient 
HPLC-CL 
HX/XOD/catalase/ 
luminol [126] 
Oxidant: O2
•− 
(HX/XOD/catalase) 
Emitter: luminol 
oxidation product 
CL 
Reagent 1: HX and luminol in 10% 
methanol/buffer (pH 8); 
Reagent 2: XOD and catalase in 
buffer (pH 8) 
Isocratic elution with MeOH/1% 
H3PO4 (28/71); eluent neutralized 
before addition of CL reagents 
HPLC-CL 
pyrogallol/EDTA/ 
luminol [127] 
Oxidant: O2
•− 
(pyrogallol); 
Emitter: luminol 
oxidation product 
CL 
Reagent 1: luminol and EDTA in 
buffer (pH 11);  
Reagent 2: aqueous pyrogallol 
0.1% H3PO4 aqueous phase 
combined with MeCN gradient  
< 65%; higher acid concentration 
or MeOH gradient caused 
baseline drift 
HPLC-PAD [9] 
Oxidant: O2
•− 
(CYPs/CYP 
reductase/HRP/ 
SOD/NADPH); 
FL-probe: 4-HPAA 
FL,  
λex 320 nm, 
λem 409 nm 
Reagent 1: CYPs, CYP reductase, 
HRP and SOD in buffer (pH 7.8);  
Reagent 2: NADPH and 4-HPAA 
in buffer (pH 7.8) 
Make-up flow with reverse 
gradient added 
CYP,  cytochrome  P450;  EDTA,  ethylenediaminetetraacetic  acid;  FL,  fluorescence;  4-HPAA,  4-
hydroxyphenylacetic acid; HPLC-CL, high performance liquid chromatography-chemiluminescence; HRP, 
horseradish peroxidase; HX, hypoxanthine; MeCN, acetonitrile; MeOH, methanol; MP11, microperoxidase-
11;  NADPH,  reduced  β-nicotinamide  adenine  dinucleotide  phosphate;  PAD,  pro-oxidant  and  antioxidant 
detection; SOD, superoxide dismutase; XOD, xanthine oxidase. Int. J. Mol. Sci. 2012, 13                       
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Both  assays  used  luminol  to  produce  CL  after  oxidation  by  the  superoxide  radical  anion.  
Ogawa et al. [128] included potassium hexacyanoferrate as catalyst, added as a third reagent before the 
reaction coil. In these two methods, inhibition of xanthine oxidase by detected compounds cannot be 
excluded. Superoxide radical anion generation using autoxidation of pyrogallol in alkaline medium 
(pH 11) has also been used in a HPLC-CL assay involving luminol [127].  
The HPLC-PAD assay described by Kool et al. [9] involves generation of both superoxide radical 
anion and hydrogen peroxide, detected using a fluorescence reaction. The system is quite complex, but 
can  detect  both  antioxidants  and  pro-oxidants.  In  a  process  catalyzed  by  cytochrome  P450s  and 
cytochrome P450 reductase, pro-oxidants in the HPLC effluent are converted by NADPH to radicals 
that react  with oxygen to form superoxide anion radicals.  In turn, the superoxide radical anion is 
converted by superoxide dismutase to hydrogen peroxide, which together with horse radish peroxidase 
reacts with 4-hydroxyphenylacetic acid to form a fluorescent product. In order to detect antioxidants, a 
pro-oxidant  like  paraquat  is  included  in  the  reagent  to  give  a  baseline  fluorescence  that  can  be 
quenched by antioxidants in the HPLC effluent. In this scenario, antioxidants can react both with the 
superoxide radical anion generated or the reduced pro-oxidant, while direct reaction with hydrogen 
peroxide and inhibition of most of the enzymes involved are also possible. 
5. Conclusions 
Development  of  on-line  HPLC-BCD  assays  provides  researchers  working  in  the  field  of 
pharmacognosy with a number of methodologies to fast-track identification of interesting and/or novel 
bioactives. In future it could become a strategic tool in the arsenal of pharmacognosists. Combined 
with MS detection and even NMR, the long and tedious process of bioassay-guided fractionation and 
isolation  for  structure  elucidation  could  be  shortened  even  further.  In  spite  of  the  advantages,  
on-line HPLC-BCD assays presently remain the domain of a limited number of research groups as 
―plug-and-play‖  systems  are  not  yet  commercially  available  and  the  number  of  methodologies 
available in on-line format are still limited. The use of commercial derivatization equipment in some 
on-line antioxidant assays makes the application of these assays more accessible.  
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